Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Antonio Regalado

A View from Antonio Regalado

Recommended Biomedicine Reads This Week

A roundup of interesting stories on biotechnology, drugs, and medicine from other sites, collected by Antonio Regalado, MIT Technology Review’s biomedicine editor.

  • October 20, 2015

Four Reasons Drugs Are Expensive, of Which Two Are False
Would you haggle over the price of shoes? How about at what price to sell your children? Prices aren’t just numbers, they have morality, and that’s why the drug industry has been consumed by debate over the high price of medicines. In very deep dive in Forbes, analyst Jack Scannell, explains why drugs cost so much.

Hot Startup Theranos Has Struggled with Its Blood-Test Technology
The Wall Street Journal investigates Theranos, the much-hyped lab-testing startup said to be worth $9 billion. The newspaper found that for most tests, the company does not even use its vaunted finger-prick technology. The accuracy of its tests are now in question and the FDA is investigating.

Searching for the Genes That Are Unique to Humans
Science writer Ed Yong reports from the annual meeting of the American Society for Human Genetics in Baltimore on the discovery of enigmatic genes that appear only in human beings, and might be behind why we can think and reason.

23andMe Wins a Second Life: New Business Plan Scores $115 Million from Investors
The Silicon Valley gene-testing startup 23andMe has one of the largest, if not the largest, collection of human DNA in the world from over 900,000 people. That alone makes it worth paying attention to, despite its business missteps and struggles with regulators.

Talk Therapy Found to Ease Schizophrenia
Talk trumps medical technology. So says a government study involving some of the two million Americans with schizophrenia. The study found that lower doses of antipsychotic drugs and more one-on-one psychiatry helped patients recover faster than those taking heavy doses of antipsychotics.

Want to go ad free? No ad blockers needed.

Become an Insider
Already an Insider? Log in.
More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe and become an Insider.
  • Insider Plus {! insider.prices.plus !}* Best Value

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Bimonthly print magazine (6 issues per year)

    Bimonthly digital/PDF edition

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special interest publications

    Discount to MIT Technology Review events

    Special discounts to select partner offerings

    Ad-free web experience

  • Insider Basic {! insider.prices.basic !}*

    {! insider.display.menuOptionsLabel !}

    Six issues of our award winning print magazine, unlimited online access plus The Download with the top tech stories delivered daily to your inbox.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Bimonthly print magazine (6 issues per year)

  • Insider Online Only {! insider.prices.online !}*

    {! insider.display.menuOptionsLabel !}

    Unlimited online access including articles and video, plus The Download with the top tech stories delivered daily to your inbox.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.